Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Disease Models & Mechanisms
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Disease Models & Mechanisms

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
RESEARCH ARTICLE
Mouse Idh3a mutations cause retinal degeneration and reduced mitochondrial function
Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, Ian J. Jackson
Disease Models & Mechanisms 2018 11: dmm036426 doi: 10.1242/dmm.036426 Published 18 December 2018
Amy S. Findlay
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy S. Findlay
Roderick N. Carter
Molecular Metabolism Group, Centre for Cardiovascular Sciences, Queens Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Becky Starbuck
MRC Mammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa McKie
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klára Nováková
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter S. Budd
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter S. Budd
Margaret A. Keighren
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph A. Marsh
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally H. Cross
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle M. Simon
MRC Mammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul K. Potter
MRC Mammalian Genetics Unit, MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas M. Morton
Molecular Metabolism Group, Centre for Cardiovascular Sciences, Queens Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian J. Jackson
MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, UKRoslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ian J. Jackson
  • For correspondence: ian.jackson@igmm.ed.ac.uk
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Idh3aE229K/E229K mice exhibit signs of retinal degeneration. (A) Idh3aE229K/E229K mice (red) showed a decline in visual acuity, as determined by optokinetic drum (OKD) score, by 12 months {0.2071±0.01872 c/d [mean±s.e.m., n=9, female (F) 4, male (M) 5]} compared with wild-type (blue) [0.3090±0.009441 c/d (mean±s.e.m., n=23, F14, M9)] (P<0.0001) and heterozygous (yellow) [0.3173±0.007472 c/d (mean±s.e.m., n=35, F24, M11)] (P<0.0001) mice. This significant decline continued and, by 18 months, homozygous mice (red) had degenerated further [0.1592±0.02396 c/d (mean±s.e.m., n=9 F4, M5)] compared with wild-type (blue) [0.3004±0.01223 c/d (mean±s.e.m., n=23, F14, M9)] (P<0.0001) and heterozygous (yellow) [0.2836±0.009699 c/d (mean±s.e.m., n=35, F24, M11)] mice (P<0.0001). Unpaired t-test, ***P<0.001. (B) Fundus imaging comparing Idh3aE229K/E229K retina with that of a wild-type littermate; the mutant retina exhibits signs of retinal degeneration, as evidenced by a dark patchy appearance. (C) Structure of the IDH3A:IDH3G heterodimer (PDB ID: 5GRI) with the positions of the E229K mutation identified in this study (red) and previously identified missense mutations (blue) highlighted. (D) Predicted effects of mutations on the stability of the IDH3A monomer and on the strength of the interaction with IDH3G. Higher values indicate greater disruption of protein stability or interaction strength.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Idh3a−/E229K and Idh3aE229K/E229K mice show early and rapid photoreceptor loss. (A) In Idh3a−/E229K mice, reactive gliosis, as indicated by green GFAP staining, is present from P30 and continues through P60-90 (n=3). This staining is not present in P30-60 Idh3aE229K/E229K, or in P90 wild-type littermates (rightmost), but is seen in P90 Idh3aE229K/E229K retinal sections (n=3). Blue staining is DAPI. (B) Histological analysis of H&E-stained eyes. The numbers of nuclei in the ONL are clearly decreased in Idh3a−/E229K at P60 and almost absent by P90. (C,D) Numbers of photoreceptor nuclei in the ONL (y-axis) at fixed distances either side of the optic nerve head (x-axis). Counts at P30 (C) show that all genotypes have normal nuclei numbers, except for the periphery of Idh3a−/E229K retinas (n=3-6, data in Table S2). By P60 and continuing to P90 (D), the numbers of nuclei are significantly decreased in Idh3aE229K/E229K retinas (n=7, F7, M2) compared with those of wild-type littermate controls (n=7, F4, M3). Unpaired t-test, *P<0.05, **P<0.01. Scale bars: 50 µm. INL, inner nuclei layer; ONL, outer nuclei layer; RGC, retinal ganglion cell layer; RPE, retinal pigmented epithelium.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Idh3a−/E229K and Idh3aE229K/E229K mice show normal then decreased photoreceptor function. (A-C) A-wave amplitudes of dark-adapted Idh3a−/E229K mice and littermate controls, exposed to a 3 cd/m3 flash of light at P30 (A) and P60 (B), with accompanying traces showing mutant (red) and wild-type (blue) scotopic responses at P30 (C, top) and P60 (C, bottom). At P30, Idh3a−/E229K mice exhibit a-wave amplitudes comparable to those of control littermates, as shown by one-way ANOVA [F(3,10)=0.7970, P=0.5232] [n=4 (F2, M2), 3 (F2, M1), 3 (F1, M2), 4 (F2, M2)], but by P60 this has significantly decreased [F(3,9)=32.66, ***P<0.001] [n=3 (M3), 3 (F1, M2), 3 (F1, M2), 5, (F1, M4)]. (D,E) Comparison of a-wave amplitudes between Idh3aE229K/E229K and wild-type controls at P60 (D) and P120 (E), respectively. At P60, mutant mice exhibit no loss of retinal function [265.5±18.18 (mean±s.e.m., n=5, F2, M3)] compared with wild-type littermates [267.0±21.3 (mean±s.e.m., n=4, F4)]. By P120, photoreceptor response to a light stimulus is significantly reduced in mutant [153.2±35.11 (mean±s.e.m., n=4, F2, M2)] compared with wild-type [247.7±15.51 (mean±s.e.m., n=4, F3, M1)] mice. *P<0.05. (F) Accompanying traces show Idh3aE229K/E229K (green) and wild-type control traces (blue) at P30 (top) and P120 (bottom).

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Mutant MEF cells exhibit reduced reserve and maximal respiration. Idh3a mutants exhibit reduced mitochondrial maximum respiration and reserve capacity. (A) Oxygen consumption (OCR) of MEF cells was measured using an Agilent Seahorse XFe24 Extracellular Flux Analyser in basal and stimulated conditions. (B-F) Histograms show maximal respiration [FCCP measurement 2 – antimycin+rotenone (Ant/Ret) measurement 2] (B), reserve capacity (FCCP measurement 2 – basal measurement 2) (C), basal respiration (basal measurement 2 – Ant/Ret measurement 2) (D), ATP respiration (basal measurement 2 – oligo measurement 2) (E), leaked respiration (oligo measurement 2 – Ant/Ret measurement 2) (F) pmol min−1 OD540−1 for each part of the experiment (A). Idh3a−/E229K and Idh3aE229K/E229K mutant cells show a lower, but not significant, trend in basal, ATP-dependent or leaked respiration compared with wild type (D-F). Both Idh3a−/E229K and Idh3aE229K/E229K showed significantly reduced maximum respiration [F(4,10)=5.701, P=0.0118] (B) and spare respiratory capacity [F(4,10)=6.536, P=0.0075] (C), as shown by one-way ANOVA. *P<0.05, **P<0.01.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Idh3b−/− mice show no signs of retinal degeneration up to 6 months. Idh3b−/− mice show no retinal degeneration up to P180. (A) GFAP green immunofluorescence on retinal sections shows no upregulation in mutant mice, indicating the absence of retinal stress (n=3). (B) ERG analysis of P180 Idh3b−/− in response to 3 cd/m3 flash under scotopic conditions shows a similar a-wave amplitude [233.4±19.63 (mean±s.e.m., n=6, F2, M4)] to that of wild-type littermates [207.7±14.42 (mean±s.e.m., n=6, F3, M3)] (left). ERG traces of mutant mice (red) also show no defects when compared with wild type (black) (right). (C-E) OCR was measured in Idh3b−/− MEF cells and compared with that of control littermates. In contrast to Idh3a mutant cells, Idh3b−/− cells did not show significantly reduced maximum respiration or spare respiratory capacity. (F) Western blot analysis for IDH3B and α-tubulin in retinal tissue shows the absence of IDH3B protein in Idh3b−/− retinas. Scale bar: 50 µm.

Tables

  • Figures
  • Table 1.
  • Table 2.
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Krebs cycle
  • Mouse model
  • Retinitis pigmentosa

 Download PDF

Email

Thank you for your interest in spreading the word on Disease Models & Mechanisms.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mouse Idh3a mutations cause retinal degeneration and reduced mitochondrial function
(Your Name) has sent you a message from Disease Models & Mechanisms
(Your Name) thought you would like to see the Disease Models & Mechanisms web site.
Share
RESEARCH ARTICLE
Mouse Idh3a mutations cause retinal degeneration and reduced mitochondrial function
Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, Ian J. Jackson
Disease Models & Mechanisms 2018 11: dmm036426 doi: 10.1242/dmm.036426 Published 18 December 2018
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
RESEARCH ARTICLE
Mouse Idh3a mutations cause retinal degeneration and reduced mitochondrial function
Amy S. Findlay, Roderick N. Carter, Becky Starbuck, Lisa McKie, Klára Nováková, Peter S. Budd, Margaret A. Keighren, Joseph A. Marsh, Sally H. Cross, Michelle M. Simon, Paul K. Potter, Nicholas M. Morton, Ian J. Jackson
Disease Models & Mechanisms 2018 11: dmm036426 doi: 10.1242/dmm.036426 Published 18 December 2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy
  • Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease
  • Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Biology Open

Advertisement

First person — Andrew Scott Emmert and Eri Iwasawa

Eri and Andrew

In an interview, first authors Andrew Scott Emmert and Eri Iwasawa discuss their new paper on impaired CSF flow and neural differentiation in a rat model of hydrocephalus, their research process and plans for the future.


Editor’s choice — Drug repurposing screening for rare diseases

Wild-type worms and pmm-2 F125L/F125L worms

Ethan Perlstein and colleagues present two back-to-back articles. In the first, they describe how the diabetic neuropathy drug palrestat can ameliorate PMM2-CDG. The second identifies the FDA-approved aripiprazole as a clinical candidate for treating NGLY1 deficiency.


Resource — SILAC-based quantitative proteomics using mass spectrometry quantifies endoplasmic reticulum stress in whole HeLa cells

Read Murgia et al.’s new resource article describing a SILAC-based proteomics approach to quantify the unfolded protein response.


Review Commons launches

We're excited to be an affiliate journal for Review Commons, the ASAPbio/EMBO platform for high-quality journal-independent peer-review in the life sciences, which went live on 09 December.

 

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About DMM
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact DMM
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2019   The Company of Biologists Ltd   Registered Charity 277992